PLAQUENIL

This brand name is authorized in Australia, Canada, Cyprus, Germany, Estonia, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Romania, Singapore, Tunisia, Turkey, United States

Active ingredients

The drug PLAQUENIL contains one active pharmaceutical ingredient (API):

1 Hydroxychloroquine UNII 8Q2869CNVH - HYDROXYCHLOROQUINE SULFATE

Hydroxychloroquine is a antimalarial agent with have several pharmacological actions which may be involved in their therapeutic effect in the treatment of rheumatic disease, but its role is not known. Read about Hydroxychloroquine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PLAQUENIL Film coated tablet	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P01BA02	Hydroxychloroquine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BA Aminoquinolines
Discover more medicines within P01BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12003R, 1512N
Country: CA	Health Products and Food Branch	Identifier(s): 02017709
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06349471, 07544217, 09510808, 09519399, 12393803
Country: EE	Ravimiamet	Identifier(s): 1027291, 1529579, 1566086, 1830529
Country: FR	Base de données publique des médicaments	Identifier(s): 67767535
Country: HK	Department of Health Drug Office	Identifier(s): 43759
Country: IE	Health Products Regulatory Authority	Identifier(s): 41000
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 481
Country: IT	Agenzia del Farmaco	Identifier(s): 013967056
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999038F1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003250, 1080353, 1081249, 1084977
Country: MT	Medicines Authority	Identifier(s): MA1359/02501, PI1438/09301A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 258M2014
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 51
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5528
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62084001, W62084002
Country: SG	Health Sciences Authority	Identifier(s): 12213P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6590011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809097872, 8699809097896, 8699809098688
Country: US	FDA, National Drug Code	Identifier(s): 59212-562, 67296-1781, 71205-448